Replies to post #733940 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

So Roswell (aka NWBO) and UCLA (aka DCVax-l combo trial) publish three articles*on November 5.

Interesting.

Particularly when two new combo patent applications in Europe&U.S. were published November 13 and 21 but were filed/published earlier in spring.

Particularly when on November 12 NWBO stated in 10q they signed a combination contract deal wherein they had designed the trial over the past many months and plan to file IND first quarter 2025. Looking more and more like Merck.

Looking more and more like info coming out on
different matters in November was no coincidence.

*total